SR-717
|
|
2375421-09-1
|
TAS-116
|
|
1260533-36-5
|
Pizuglanstat
|
|
1244967-98-3
|
Amcasertib(BBI503)
|
|
1129403-56-0
|
NVP-BHG 712
|
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺
|
940310-85-0
|
PF-5274857
|
|
1373615-35-0
|
Samatasvir
|
|
1312547-19-5
|
FB23-2
|
|
2243736-45-8
|
KX2-391
|
5-[4-[2-(4-嗎啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺
|
897016-82-9
|
BI-749327
|
|
2361241-23-6
|
SU0268
|
|
2210228-45-6
|
SJB2-043
|
2-苯基萘并[2,3-D]惡唑-4,9-二酮
|
63388-44-3
|
Apilimod mesylate
|
阿吡莫德甲磺酸鹽
|
870087-36-8
|
BI-D1870
|
|
501437-28-1
|
Endovion
|
|
265646-85-3
|
NPS 2390
|
|
226878-01-9
|
V-9302 HCl
|
(S)-2-氨基-4-(bis(2-((3-甲基芐基)氧基)芐基)氨基)丁酸鹽酸鹽
|
2416138-42-4
|
ZSTK474
|
|
475110-96-4
|
HAT Inhibitor II
|
|
932749-62-7
|
AZD9574
|
|
2756333-39-6
|
SPD-304
|
化合物CS 2594
|
869998-49-2
|
Pyr6
|
|
245747-08-4
|
|
3,5-二溴-4-氯-1H-吡唑
|
27258-21-5
|
|
1-丙基-3-(4,4,5,5-四甲基-1,3,2-二氧雜硼烷-2-基)-1H-吡唑
|
934586-51-3
|
|
5-溴-2-(溴甲基)苯甲腈
|
156001-53-5
|
Tilfrinib
|
|
1600515-49-8
|
|
2-(吡咯烷-1-基甲基)苯基硼酸
|
878289-40-8
|
|
2-(4 - ((4 - ((4 - ((2-氯苯基)氨基甲?;?苯基)氨基)-5-氟嘧啶-2-基)
|
1158838-42-6
|
P276-00
|
|
920113-03-7
|
|
|
97978-07-9
|
Rhosin
|
(R,E)-2-氨基-3-(1H-吲哚-3-基)-N'-(喹喔啉-6-基亞甲基)丙酰肼
|
1281870-42-5
|
ZINC05007751
|
|
591239-68-8
|
AM1241
|
(2-碘-5-硝基苯基)(1-((1-甲基哌啶-2-基)甲基)-1H-吲哚-3-基)甲酮
|
444912-48-5
|
BMS-191011
|
3-(5-氯-2-羥基芐基)-5-(4-(三氟甲基)苯基)-1,3,4-惡二唑-2(3H)-酮
|
202821-81-6
|
RP70676
|
|
136609-26-2
|
3PO
|
(E)-3-吡啶-3-基-1-吡啶-4-基 - 丙烯酮;
|
18550-98-6
|
|
|
2177293-82-0
|
Tazanolast
|
他扎司特
|
82989-25-1
|
CapmatinibHClhydrate(INCB-28060)
|
鹽酸卡瑪替尼一水合物
|
1865733-40-9
|
AS2444697
|
|
1287665-60-4
|
Azidamfenicol
|
|
13838-08-9
|
SBI-425
|
化合物SBI-425
|
1451272-71-1
|
GNE-781
|
|
1936422-33-1
|
EGFR-IN-7
|
|
2267329-76-8
|
WM3835
|
|
2229025-70-9
|
Givinostat (ITF2357)
|
N-[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯鹽酸鹽
|
732302-99-7
|
KN-93 hydrochloride
|
|
1956426-56-4
|
CID755673
|
|
521937-07-5
|
dCBP-1
|
|
2484739-25-3
|
PF-06882961
|
|
2230198-02-2
|
GSK 2118436(SB 590885)
|
5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氫-1-茚酮肟
|
405554-55-4
|
OICR-9429
|
|
1801787-56-3
|
|
|
898563-49-0
|
PHT-427
|
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺
|
1191951-57-1
|
Acitazanolast
|
阿扎司特
|
114607-46-4
|
MG149
|
|
1243583-85-8
|
APY0201
|
化合物APY0201
|
1232221-74-7
|
SP-13786
|
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺
|
1448440-52-5
|
pipequaline.HCl
|
|
80221-58-5
|
F-15599
|
|
635323-95-4
|
Dynarrestin
|
|
2222768-84-3
|
TC-DAPK 6
|
2-(2-苯乙烯基)-4-(3-吡啶基亞甲基)-5(4H)-惡唑酮
|
315694-89-4
|
YQ128
|
|
2454246-18-3
|
|
(6R)-5,6,7,8-四氫生物蝶呤二鹽酸鹽
|
69056-38-8
|
ANR 94
|
|
634924-89-3
|
1,2-bis(2-chloropyridin-3-yl)diselane
|
|
1094062-82-4
|
PSB-12062
|
|
55476-47-6
|
GSK-3β inhibitor 1
|
|
187325-53-7
|
ABT-724
|
2 - [(4-吡啶-2-基哌嗪-1-基)甲基]-1H-苯并咪唑 1級(jí)
|
70006-24-5
|
JNJ63576253 HCl
|
|
2110428-64-1
|
ML267
|
|
1542213-67-1
|
Travoprost acid
|
|
221246-34-0
|
PF-06873600
|
|
2185857-97-8
|
EN4
|
|
1197824-15-9
|
MAO-B-IN-2
|
|
1253978-24-3
|
|
:4H,5H,6H,7H,8H-環(huán)庚烷[D][1,2]噁唑-3-羧酸;5,6,7,8-TETRAHYDRO-4 H-CYCLOHEPTA[ D ]ISOXAZOLE-3-CARBOXYLIC ACID
|
33230-32-9
|
MB-07344
|
((4-(4-羥基-3-異丙基苯甲基)-3,5-二甲基苯氧基)甲基)膦酸
|
852947-39-8
|
LUN76721
|
|
4376-72-1
|
BRM/BRG1 ATP Inhibitor-1
|
|
2270879-17-7
|
JH-X-119-01
|
|
2227368-54-7
|
WAY-312778
|
化合物WAY-312778
|
301157-29-9
|
Ro60-0175
|
|
169675-08-5
|
I-BET567
|
|
1887237-54-8
|
CDK4/6-IN-6CDK4/CDK4/6-IN-66-IN-6
|
|
2380321-51-5
|
|
5-(羥甲基)噻吩-2-甲腈
|
172349-09-6
|
BML-277
|
2-(4-(4-氯苯氧基)苯基)-1H-苯并[d]咪唑-6-甲酰胺
|
516480-79-8
|
Pyr10
|
|
1315323-00-2
|
KKL-35
|
|
865285-29-6
|
ISCK03
|
|
945526-43-2
|
YM-58483
|
|
223499-30-7
|
KA2507
|
產(chǎn)品Benzamide
|
1636894-46-6
|
KB-0742 HCl
|
|
2416873-83-9
|
SD49-7
|
2-羥基-1-萘甲醛水楊酰腙
|
54009-54-0
|
SGK1-IN-4
|
|
1628048-93-0
|
BC1618
|
|
2222094-18-8
|
|
3-羥基-5-戊基環(huán)己-2-烯-1-酮
|
58016-29-8
|
GSK329
|
化合物GSK329
|
1268490-12-5
|
|
6,7-二氟-1H-苯并[d]咪唑-2-羧酸
|
1225283-27-1
|
|
|
1806777-93-4
|
WAY-661957
|
化合物WAY-661957
|
899902-32-0
|
|
|
39640-08-9
|